Market
Medtronic raises FY27 outlook after reporting strong Q1 growth
Medtronic raised its fiscal 2027 outlook following strong first-quarter results, with cardiac ablation solutions delivering 29.5% year-over-year growth as the electrophysiology business's top performer. The company's positive guidance reflects momentum across its portfolio segments.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network